Global Macrolide Antibiotics Market, By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Rising demand for pharmaceutical drugs against bacterial skin infections will induce growth in the demand for macrolide antibiotics. Data Bridge Market Research analyses that the macrolide antibiotics will exhibit a CAGR of around 12.5% for the forecast period of 2021-2028.
Macrolide antibiotics are the antibiotics against bacteria derived from saccharopolyspora erythraea. Macrolide antibiotics are bacteriostatic; however, they may be bactericidal at high concentration of bacterial strain. Currently, five types of macrolide antibiotics are available in the market namely erythromycin, clarithromycin, azithromycin, fidaxomicin and telithromycin. These possess anti-inflammatory and immune modulatory effects which are used for certain health conditions like respiratory condition, treating soft tissue, sexually transmitted bacterial infections and much more.
Growth and expansion of antibiotics market will subsequently promote the growth of macrolide antibiotics market. Rising prevalence of bacterial skin infections will further induce the growth of macrolide antibiotics market. Supportive government policies and legislations will further create lucrative growth opportunities for the macrolide antibiotics market.
Consumption of macrolide antibiotics may increase the risk of sudden cardiovascular death in patients. This will pose a major challenge to the growth of macrolide antibiotics market. Liver injuries are another effect of consumption of macrolide antibiotics. This will also restrict the scope of growth. Availability of generic drugs in the market will yet again pose a threat to the macrolide antibiotics market growth.
This macrolide antibiotics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on macrolide antibiotics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Macrolide Antibiotics Market Scope and Market Size
The macrolide antibiotics market is segmented on the basis of drugs, route of administration, infection and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the drugs, the macrolide antibiotics market has been segmented into azithromycin, clarithromycin, erythromycin, fidaxomicin and telithromycin.
- Based on the route of administration, the macrolide antibiotics market has been segmented into oral and parenteral.
- On the basis of infection, the macrolide antibiotics market is segmented into mycoplasma pneumoniae, legionella sp., bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosishepatis, cerebral toxoplasmosis and uncomplicated skin infections.
- On the basis of end user, the macrolide antibiotics market is segmented into hospital, dermatology clinic, clinic, ambulatory centre and research laboratories.
Macrolide Antibiotics Market Country Level Analysis
The macrolide antibiotics market is analysed and market size insights and trends are provided by country, drugs, route of administration, infection and end user as referenced above.
The countries covered in the macrolide antibiotics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the macrolide antibiotics market owing to the prevalence of sophisticated healthcare infrastructure, increased research and development proficiencies by the pharmaceutical companies and rapid adoption of new and better healthcare technologies. Presence of leading manufacturers in the region is also responsible for propelling market growth. Asia-Pacific on the other hand is projected to score highest growth rate for the forecast period owing to rising expenditure to develop healthcare infrastructure, rising prevalence of bacterial skin diseases. Growing awareness about the use of macrolide antibiotics is further inducing market growth in this region.
The country section of the macrolide antibiotics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Macrolide antibiotics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for macrolide antibiotics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital health technologies market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Macrolide Antibiotics Market Share Analysis
The macrolide antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to macrolide antibiotics market.
The major players covered in the macrolide antibiotics market report are GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly And Company., Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Boehringer Ingelheim International Gmbh, Sanofi, Astrazeneca, AbbVie Inc., Abbott, Bayer AG, Sandoz International GmbH, Johnson & Johnson Services, Inc., www.bpharmed.com, Zhejiang Guobang Pharmaceutical Co., Ltd. and Barkat Pharmaceutical Group among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Macrolide Antibiotics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.